Neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target. The researchers found that this mechanism — a type of signaling termed constitutive or non-canonical epidermal growth factor receptor (EGFR) signaling — is highly active in glioblastomas, the most common type of adult brain cancer and a devastating disease with a poor prognosis.